Hikal Limited

Hikal Limited is a premier, innovation-driven technology company headquartered in Navi Mumbai, India, that operates as a trusted long-term partner for global companies in the Pharmaceuticals, Crop Protection, and Specialty Chemicals industries. Founded in 1988, Hikal has built a formidable reputation for its deep expertise in custom synthesis and contract manufacturing.

In its Pharmaceutical division, Hikal manufactures a diverse range of Active Pharmaceutical Ingredients (APIs) and advanced intermediates, supporting therapeutic categories such as CNS (Central Nervous System), anti-diabetics, and anti-inflammatory drugs. A standout feature of Hikal is its dominance in specific niche molecules; for example, it is one of the world’s largest suppliers of the neuropathy drug Gabapentin.

The company operates multiple world-class, massive manufacturing sites across Gujarat and Maharashtra, all rigorously compliant with strict global standards, including US FDA, PMDA, and EDQM approvals. Hikal places a strong emphasis on continuous technological innovation, heavily investing in R&D to pioneer greener, more cost-effective manufacturing routes. They are particularly recognized for their advanced capabilities in biocatalysis and enzymatic processes, which significantly reduce environmental impact.

The organization is also highly committed to stringent Intellectual Property (IP) protection, making it a safe and reliable partner for innovator companies looking to outsource the manufacturing of their New Chemical Entities (NCEs). Through its commitment to quality, sustainability, and collaborative partnership, Hikal remains a cornerstone of the global chemical and pharmaceutical manufacturing landscape.